Single Dose Escalation Study of PF-05190457 in Healthy Volunteers

NCT01247896 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type II

Interventions

DRUG: PF-05190457
DRUG: PF-05190457
DRUG: PF-05190457
DRUG: PF-05190457
DRUG: PF-05190457
DRUG: PF-05190457
DRUG: PF-05190457
DRUG: PF-05190457
DRUG: Placebo

Sponsor

Pfizer